Development of pk/pd Model of Propofol in Patients With Severe Burns (HUAPQ)
Development of Pharmacokinetic / Pharmacodynamic (pk/pd) Model of Propofol in Patients With Severe Burns
Sponsor: Pontificia Universidad Catolica de Chile
Terminated
Outbreak COVID 19
Other terminated trials from Pontificia Universidad Catolica de Chile
- Infant, Premature, Diseases · Phase NA · Aug 2024
- Anesthesia · Oct 2021
- Ureteral Calculi · Phase PHASE4 · Jan 2020
- Anesthesia · Mar 2018
- Premature Infant Disease · Phase NA · Jul 2017
See all terminations from Pontificia Universidad Catolica de Chile
Listed as NCT03704285, this observational or N/A phase trial focuses on Anesthesia and Burned and remains terminated or withdrawn. Sponsored by Pontificia Universidad Catolica de Chile, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2022 — Jul 2024 [monthly]
Terminated
Status: Suspended → Terminated
-
Feb 2021 — Apr 2022 [monthly]
Suspended
-
Jan 2021 — Feb 2021 [monthly]
Suspended
▶ Show 5 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Suspended
Status: Recruiting → Suspended
-
Apr 2020 — Oct 2020 [monthly]
Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting
-
Mar 2019 — Feb 2020 [monthly]
Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Recruiting
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pontificia Universidad Catolica de Chile
- Victor Contreras, MSN
For direct contact, visit the study record on ClinicalTrials.gov .